Climb Bio (CLYM) Non Operating Income (2024 - 2026)
Climb Bio (CLYM) posted Non Operating Income of $1.5 million for Q1 2026, down 25.7% on a QoQ basis from $2.0 million in Q3 2025, and down 33.44% year-over-year from $2.2 million in Q1 2025.
Climb Bio (CLYM) Non Operating Income (2024 - 2026) Analysis & Trends
Climb Bio's Non Operating Income history runs 3 years deep, the most recent figure standing at $1.5 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | 1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.49 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 1.48 Mn |